G. Grandits

发表

Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected

J. Lundgren, P. Mollie, G. Grandits, 2014 .

Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals.

E. Soliman, J. Lundgren, M. Roediger, 2014, Biomarkers in medicine.

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Gretchen A. Stevens, J. Gallacher, J. Danesh, 2019, The Lancet. Global health.

Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.

L. Kuller, R. Prineas, J. Neaton, 2007, Atherosclerosis.

Long-term cardiovascular mortality among middle-aged men with gout.

L. Kuller, J. Neaton, E. Krishnan, 2008, Archives of internal medicine.

Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies

Mark Woodward, Shah Ebrahim, Johan Sundström, 2013, American journal of epidemiology.

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

K. W. Davidson, J. Gallacher, J. Danesh, 2012, International journal of epidemiology.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Karla P. Zepeda, Christina C. Chang, Kamil H A Kim, 2022, Annals of Internal Medicine.

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Christina C. Chang, R. Hyzy, Akram Khan, 2022, The Lancet Respiratory Medicine.

Dietary sodium intake and mortality MRFIT follow-up study results

J. Cutler, J. Neaton, J. Stamler, 1999 .

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa

S. Migueles, C. Reilly, G. Grandits, 2021, PloS one.

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

B. Gazzard, E. Soliman, A. Phillips, 2017, Journal of the American Heart Association.

Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study.

E. Soliman, J. Lundgren, M. Roediger, 2014, Journal of electrocardiology.

Multiple Risk Factor Intervention Trial Revisited: A New Perspective Based on Nonfatal and Fatal Composite Endpoints, Coronary and Cardiovascular, During the Trial

J. Cutler, L. Kuller, L. Eberly, 2012, Journal of the American Heart Association.

A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.

Michael A. Polis, J. Neaton, S. Emery, 2010, The Journal of infectious diseases.

Morbidity and Mortality According to Latest CD4+ Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa

Paul Khabo, Lotty Ledwaba, James D. Neaton, 2015, PloS one.

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

Christina C. Chang, W. Self, A. Ginde, 2022, American journal of respiratory and critical care medicine.

Elevated prostate-specific antigen levels up to 25 years prior to death from prostate cancer.

Avis J. Thomas, L. Kuller, J. Neaton, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS).

R. Prineas, J. Neaton, J. Stamler, 1995, Circulation.

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial Network for Strategic Initiatives in Global HIV Trials) START (Strategic of Antiretroviral

A. Phillips, S. Spector, S. Emery, 2018 .

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

J. Gallacher, J. Danesh, E. Rimm, 2012, International journal of epidemiology.

Early cardiovascular structural and functional abnormalities as a guide to future morbid events.

J. Cohn, D. Duprez, S. Duval, 2020, European journal of preventive cardiology.